mannosidas
see
support
inform
core
moder
inhibitori
activ
amannosidas
afucosidas
librari
gener
screen
bglucosidas
nacetylbhexosaminidas
studi
mixtur
iminocyclitol
carboxyl
acid
equiv
scheme
diisopropyl
ethylamin
diea
equiv
tetramethyl
uronium
hexafluorophosph
hbtu
equiv
dmso
shaken
microtit
plate
h
crude
reaction
product
randomli
select
analyz
esim
ensur
presenc
desir
product
reaction
mixtur
dilut
appropri
buffer
solut
transfer
anoth
microtit
plate
screen
directli
without
purif
base
ic
valu
see
support
inform
concentr
reaction
product
set
mm
bglucosidas
mm
bhexosaminidas
assum
amid
format
complet
percentag
inhibit
rel
control
calcul
basi
absorb
nm
pnitrophenol
releas
correspond
substrat
compound
gener
amideform
reaction
sever
inhibitor
found
see
support
inform
good
inhibitor
enzym
select
resynthes
pure
compound
reevalu
determin
ic
k
valu
tabl
scheme
screen
wwwchembiochemorg
aglucosidas
baker
yeast
inhibit
twothird
reaction
product
found
potent
see
support
inform
overal
librari
inhibitori
activ
briefli
aglucosidas
inhibit
greater
extent
compound
contain
fusedaromat
ring
eg
heteroaromat
compon
eg
worth
note
enzym
interact
bicycl
trior
monocycl
aglycon
eg
vs
vs
aglucosidas
bacillu
stearothermophilu
also
investig
librari
result
similar
baker
yeast
potent
one
yeast
aglucosidas
compound
k
valu
nm
select
aover
bglucosidas
interestingli
ic
valu
compound
aglucosidas
twotothre
order
magnitud
differ
result
suggest
lipophil
bind
pocket
exist
allow
bicycl
ring
indol
naphthalen
fit
specif
orient
bicycl
ring
also
import
screen
bglucosidas
almond
onesixth
reaction
product
found
compar
potent
aiminocyclitol
show
weaker
effect
bglucosidas
aglucosidas
dimethylamino
group
attach
aromat
ring
could
enhanc
inhibitori
activ
eg
document
previous
particular
structur
transcinnam
moieti
shown
significantli
inhibit
enzym
especi
metahalogen
substitu
eg
transcinnam
moieti
board
rang
biolog
properti
includ
hepatoprotect
antimalari
antioxid
find
suggest
new
applic
transcinnam
acid
deriv
inhibitori
reaction
product
inhibit
k
valu
mm
gener
deriv
select
athan
bglucosidas
inhibitor
inhibit
jack
bean
nacetylbhexosaminidas
seem
greater
hydrophil
substitu
posit
eg
howev
none
substitu
potent
acetamido
group
indic
crucial
role
enzym
activ
site
studi
also
show
potent
inhibitor
bhexosaminidas
found
deriv
though
rel
weaker
inhibitor
bglucosidas
observ
overal
combinatori
synthesi
follow
rapid
screen
situ
describ
provid
platform
identifi
select
glycosidas
inhibitor
modif
common
transitionst
core
aglycon
side
chain
ruse
previous
report
antiviru
effect
nnnonyl
dnj
nndnj
flaviviru
infect
howev
fivememb
iminocyclitol
test
antivir
activ
potent
aglucosidas
inhibitor
hand
test
potenti
antivir
effect
base
previou
assay
system
jev
detail
antiviru
assay
given
experiment
section
compound
exhibit
inhibit
mm
data
shown
peracetyl
compound
believ
increas
cellular
uptak
convert
compound
cellular
esteras
subject
cell
assay
howev
also
show
inhibit
mm
data
shown
turn
attent
modifi
ring
nitrogen
potent
aglucosidas
inhibitor
sidechain
modif
alkyl
dnj
previous
report
enhanc
abil
inhibit
glycan
process
viru
product
studi
influenc
alkylchain
length
cellbas
assay
seri
compound
alkyl
chain
rang
c
c
attach
compound
synthes
use
reduct
amin
appropri
aldehyd
give
rise
compound
scheme
inhibit
activ
nalkyl
deriv
aand
bglucosidas
also
investig
see
support
inform
result
show
molecul
still
aglucosidas
select
albeit
low
activ
compar
parent
compound
result
also
observ
vitro
antiaglucosidas
activ
dnj
nndnj
cellbas
sodium
phennylamino
carbonyl
bi
benzen
sulfon
acid
hydrat
xtt
assay
measur
cell
prolifer
indic
compound
toxic
mm
figur
except
compound
show
low
level
cytotox
gener
alkyl
iminocylitol
activ
jev
infect
figur
b
rel
viru
titer
deriv
cell
treat
nndnj
newli
synthes
molecul
less
potent
infect
figur
c
howev
antijev
infect
compound
potent
nndnj
compound
figur
appear
less
cytotox
potent
ic
mm
ic
mm
tabl
present
studi
compound
chain
length
nine
ten
twelv
carbon
respect
found
optim
antivir
activ
similar
effect
also
notic
varicella
zoster
viru
longer
alkyl
chain
decyl
chain
compound
provid
modest
increas
potenc
cellbas
assay
also
result
increas
cytotox
presum
due
disrupt
lipid
bilay
structur
perspect
alkyl
iminocyclitol
view
consist
two
distinct
molecular
element
imino
sugar
head
group
nalkyl
side
chain
head
group
recogn
eraglucosidas
role
tail
shown
nndnj
unclear
might
abl
insert
membran
increas
local
concentr
near
membraneassoci
er
glucosidas
recent
studi
nnonyldeoxygalactonojirimycin
nndgj
galactosetyp
iminocyclitol
found
still
antihbv
antibvdv
activ
although
lack
abil
inhibit
aglucosidas
observ
suggest
nndnj
might
possess
differ
antivir
mechan
nevertheless
found
nndgj
inhibit
either
jev
cellbas
assay
system
weaker
aglucosidas
inhibitor
deriv
core
eight
ten
carbon
scheme
evalu
found
mm
inhibit
either
jev
infect
data
shown
cellbas
assay
inhibitor
also
screen
infect
sarscov
follow
previous
establish
procedur
ic
compound
around
mm
antivir
effect
compound
jev
sarscov
shown
present
studi
like
mediat
inhibit
er
aglucosidas
howev
possibl
mechan
besid
aglucosidas
inhibit
rigor
exclud
discoveri
potent
human
bhexosaminidas
inhibitor
previou
studi
compound
nmethyl
deriv
acetamidomethyl
hydroxymethyl
pyrrolidin
found
potent
inhibitor
human
nacetylbhexosaminidas
k
nm
particular
incub
human
chondrosarcoma
cell
iminocyclitol
result
accumul
glycosaminoglycan
gag
cellassoci
fraction
decreas
releas
gag
cultur
supernat
discoveri
iminocyclitol
potenti
chondroprotect
agent
suggest
new
avenu
develop
drug
treat
osteoarthr
order
improv
potenc
consider
effort
direct
toward
modif
ring
nitrogen
nitrogen
iminocyclitol
howev
none
synthes
inhibitor
potent
compound
structureact
relationship
iminocyclitol
reveal
acetamido
group
posit
crucial
activ
site
pocket
bhexosaminidas
toler
larger
substitu
methyl
group
ring
nitrogen
enhanc
inhibit
activ
wherea
aromat
ring
substitu
caus
decreas
inhibit
activ
altern
approach
increas
potenc
probe
distant
aglyconbind
site
bhexosaminidas
therefor
decid
attach
longchain
alkyl
group
termin
amin
ring
nitrogen
reduct
anim
result
primari
amin
easi
diversifi
amidebond
format
gener
librari
mention
strategi
began
reduct
amin
compound
aldehyd
differ
length
give
compound
scheme
intermedi
either
deprotect
acid
condit
hydrogenolyz
give
primari
amin
first
attempt
gener
librari
compound
amidebond
format
mention
highthroughput
screen
show
compound
significantli
enhanc
inhibitori
activ
data
shown
thu
inhibit
studi
compound
human
placenta
nacetylbhexosaminidas
carri
nacetylbdglucosaminid
use
substrat
appar
k
v
max
valu
substrat
calcul
lineweaverburk
doubl
reciproc
plot
k
valu
determin
replot
k
app
versu
inhibitor
concentr
compound
potent
competit
inhibitor
k
valu
nm
figur
interestingli
vari
linkag
npropyl
noctyl
compound
observ
trend
human
bhexosaminidas
inhibit
compound
heptamin
moieti
strongest
inhibitor
attempt
optim
inhibitor
linker
replac
ethylen
glycol
chain
hydrophil
linker
give
compound
k
nm
moder
nalkyl
chain
give
compound
k
nm
respect
howev
modif
neg
effect
indic
import
role
amino
group
lipophil
chain
compound
crystal
structur
human
bhexosaminidas
b
avail
complex
model
reveal
narrow
hydrophob
cleft
activ
site
mainli
enclos
sidechain
group
residu
backbon
residu
figur
amino
group
termin
site
expect
larg
proton
bind
enzym
presum
form
salt
bridg
secondari
aglycon
bind
site
enzym
appear
alkyl
linkag
long
enough
bring
amin
end
near
enough
hydrogenbond
interact
backbon
carbonyl
possibl
ionic
interact
carboxyl
group
base
structur
appli
combinatori
synthesi
microtit
plate
situ
screen
method
power
procedur
rapidli
identifi
signific
bindingsit
differ
among
similar
enzym
develop
potent
select
inhibitor
inhibitor
aglucosidas
structur
bicycl
ring
indol
naphthalen
gave
best
wwwchembiochemorg
hibitori
potenc
illustr
k
valu
nm
increas
activ
compar
parent
core
nalkyl
deriv
compound
also
test
antivir
activ
contain
lipophil
alkyl
group
activ
ic
mm
jev
sarscov
infect
given
import
role
osteoarthr
inhibit
nacetylbhexosaminidas
investig
regard
substitu
effect
nitrogen
ring
nitrogen
core
result
show
acetamido
group
posit
crucial
modif
ring
nitrogen
aromat
group
caus
loss
inhibit
howev
extend
alkyl
chain
ring
nitrogen
gave
potent
human
bhexosaminidas
inhibitor
known
date
compound
k
valu
nm
model
indic
strong
bind
compound
bhexosaminidas
lipophil
cleft
ionic
interact
secondari
bind
site
altogeth
work
clearli
demonstr
effect
simpl
combinatori
approach
strategi
rapid
discoveri
potent
inhibitor
potenti
candid
medic
applic
materi
sourc
enzym
follow
gener
method
chemic
synthesi
nonaqu
reaction
run
ovendri
vacuumcool
glasswar
nitrogen
atmospher
reaction
monitor
thinlay
chromatographi
merck
silica
gel
util
ninhydrin
panisaldehyd
cerium
molybd
stain
reagent
silica
gel
use
flash
column
chromatographi
mallinckrodt
type
mesh
unless
otherwis
note
reagent
materi
obtain
commerci
sourc
use
provid
without
purif
h
c
nmr
spectra
record
bruker
spectromet
referenc
residu
solvent
peak
cdcl
h
gener
procedur
coupl
reaction
situ
screen
carboxyl
acid
ml
mm
stock
solut
dmso
mmol
hbtu
ml
mm
stock
solut
dmso
equiv
mmol
diea
ml
mm
stock
solut
dmso
equiv
mmol
ad
dmso
ml
well
microtit
plate
reaction
initi
ad
compound
ml
mm
stock
solut
mmol
well
reaction
mixtur
shaken
room
temperatur
h
monitor
complet
base
disappear
tlc
mobil
phase
chcl
meohnh
oh
r
f
aliquot
ml
withdrawn
previou
reaction
mixtur
mix
phosphat
buffer
ml
ph
reach
dilut
procedur
repeat
give
desir
dilut
ie
final
concentr
mm
product
well
microtit
plate
well
anoth
plate
aglucosidas
baker
yeast
ml
u
ml
pnitrophenylaglucopyranosid
ml
mm
mix
aliquot
ml
aforement
mixtur
ml
buffer
mm
inhibitor
enzym
inhibit
assay
enzym
assay
gener
procedur
assay
variou
glycosidas
initi
veloc
hydrolysi
measur
spectrophotometr
variou
concentr
pnitrophenylglycopyranosid
mm
mm
mm
mm
mm
mm
mm
nm
use
bio
assay
reader
perkinelm
ht
plu
obtain
data
fit
michaelismenten
equat
use
kaleida
graph
program
determin
appar
k
valu
substrat
concentr
use
threeto
fivefold
k
valu
evalu
inhibitori
effect
variou
glycosidas
give
ideal
progress
curv
appropri
enzym
concentr
unit
per
ml
inhibitor
concentr
nm
mm
use
inhibitori
concentr
ic
determin
concentr
veloc
hydrolysi
reduc
compar
untreat
control
assay
perform
well
microtit
plate
contain
either
sodium
phosphat
buffer
mm
ph
aand
bglucosidas
aand
bgalactosidas
aand
bmannosidas
afucosidas
mcilvain
buffer
mm
ph
nacetylbhexosaminidas
jack
bean
cell
line
virus
viru
infect
cell
cultur
rpmi
medium
contain
fetal
bovin
serum
fb
lglutamin
mm
jev
strain
taiwanes
strain
use
studi
viru
propag
carri
cell
use
rpmi
medium
contain
fb
inhibitor
dissolv
dmso
infect
jev
monolay
cell
sixor
plate
adsorb
viru
h
adsorpt
unbound
virus
remov
gentl
wash
serumfre
medium
follow
addit
fresh
medium
contain
variou
amount
inhibitor
incub
determin
viru
titer
cultur
media
harvest
plaqueform
assay
variou
viru
dilut
ad
confluent
cell
incub
h
adsorpt
cell
wash
overlaid
agaros
seaplaqu
fmc
bioproduct
cambrix
bioscienc
rockland
usa
contain
rpmi
fb
incub
day
jev
day
cell
fix
formaldehyd
stain
crystal
violet
inhibitor
concentr
requir
inhibit
viru
product
ic
ic
determin
indirect
immunofluoresc
assay
ifa
cell
fix
acetonemethanol
min
treat
monoclon
antibodi
mab
jev
wash
phosphatebuff
salin
pb
cell
stain
goat
antimous
fluorescein
isothiocyan
fitc
conjug
secondari
antibodi
jackson
immunoresearch
west
grove
pa
usa
result
cell
examin
leica
fluoresc
microscop
viral
protein
express
ifa
read
fluoresc
micropl
reader
molecular
devic
excit
wavelength
nm
emiss
wavelength
nm
data
shown
percentag
infect
cell
versu
without
inhibitor
treatment
none
cell
nuclei
visual
dapi
stain
sodium
chlorid
room
temperatur
min
xtt
assay
determin
cell
viabil
colorimetr
xttbase
assay
perform
cell
prolifer
kit
ii
roch
cell
plate
incub
variou
concentr
inhibitor
day
xtt
label
reagent
ad
cultur
medium
cell
incub
min
read
elisa
reader
nm
molecular
devic
primari
screen
antisarscov
activ
vero
cell
per
well
cultur
plate
dulbecco
modifi
eagl
medium
dmem
supplement
fb
cultur
medium
remov
day
incub
cell
reach
confluenc
solut
dmem
ml
fb
contain
compound
test
place
three
well
cell
incub
co
incub
h
inocul
sarscov
hk
strain
dose
tcid
per
well
cytopath
morpholog
cell
examin
use
invert
microscop
h
infect
comput
model
dock
experi
conduct
use
autodock
lamarckian
genet
algorithm
lga
crystal
structur
human
bhexosaminidas
b
complex
transitionstateanalogu
inhibitor
dlacton
download
rcsb
protein
data
bank
pdb
code
chain
structur
extract
util
dock
simul
structur
model
inhibitor
built
cach
fujitsu
japan
refin
perform
optim
geometri
calcul
mechan
use
augment
paramet
store
pdb
format
mgltool
molecular
graphic
lab
scripp
research
institut
use
proteinstructur
prepar
paramet
creation
meet
input
requir
autodock
briefli
essenti
hydrogen
atom
ad
structur
model
hexosaminidas
follow
assign
kollman
unit
atom
charg
solvat
paramet
compound
molecul
assign
gasteigermarsili
charg
nonpolar
h
atom
merg
torsion
defin
autogrid
tool
autodock
appli
produc
energi
grid
xyz
direct
space
variou
type
compound
atom
grip
map
center
activ
site
dlacton
bound
dock
experi
compound
kept
flexibl
protein
kept
rigid
soli
wet
local
search
method
lga
appli
gener
avail
conform
compound
structur
within
activ
site
conform
search
conduct
util
quaternion
torsion
step
compound
structur
maximum
energi
unit
evalu
pose
select
gener
per
run
plausibl
dock
mode
select
abund
cluster
rmsd
strongest
affin
energi
pictur
final
simul
complex
gener
mgltool
wwwchembiochemorg
